麻醉和喉罩市場：按細分市場劃分的規模、份額、法規、報銷、程序和 2033 年預測

患有慢性阻塞性肺病等呼吸系統疾病的大量老年族群是市場的關鍵驅動力。 聯合國預測，到 2050 年，60 歲及以上人口將達到 20 億，成長速度明顯快於總人口成長速度，年增率約 3%（UNDESA，2017）。 人口老化影響健康和醫療保健，而醫療設備是醫療保健服務的重要組成部分。

此外，由於吸菸和空氣品質差，全球患有慢性阻塞性肺病的人口持續成長。 據估計，全球有超過2億人患有慢性阻塞性肺病，其中超過6,500萬人患有中度至重度慢性阻塞性肺病。 慢性阻塞性肺病是全球第三大死因。 麻醉和喉罩與急慢性呼吸道疾病的治療領域高度相關。 一項研究表明，慢性阻塞性肺病患者使用長期非侵入性通氣可將相對死亡風險降低 60% 以上。

由於COPD患者數量的增加，急診醫院市場和家庭醫療市場規模不斷擴大。 麻醉面罩和喉罩通常用於醫院、家庭環境和療養院，作為非侵入性呼吸器和氣道正壓裝置的病人介面。 這些面罩可從設備製造商和第三方供應商處取得。 不同介面的選擇取決於通氣的有效性和患者對通氣的耐受性。

本報告深入探討了全球麻醉和喉罩市場，包括競爭格局、SWOT 分析、到 2033 年的市場預測、COVID-19 的影響、區域和國家趨勢等。

目錄

目前麻醉喉罩市場及競爭狀況

• 對主要產業趨勢的見解
• 2015 年至 2033 年麻醉及喉罩各細分市場的市場總收入及市場前景
• 按細分市場劃分的手術總數、單位數量、平均售價和市場價值的詳細數據

全球、區域與國家見解

• 麻醉及喉罩市場SWOT分析
• 麻醉和喉罩市場的競爭動態洞察和趨勢
• 各國醫療保健系統概覽
• 按國家/地區劃分的報銷政策
• 各國醫療科技的監管狀況

Anesthesia and Laryngeal Masks Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Anesthesia and Respiratory Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Anesthesia and Laryngeal Masks market for the year 2020 and beyond. The large geriatric population base, suffering from respiratory diseases such as COPD, is the primary driver of the market. The United Nations estimates that the population of individuals of ages over 60 will reach two billion in 2050 with a growth rate of about 3% annually, considerably faster than the population as a whole (UNDESA, 2017). Population aging affects health and healthcare, and medical devices are a crucial component of healthcare delivery.

In addition, the global population with COPD continues to expand due to smoking and poor air quality. More than 200 million people worldwide are estimated to have COPD, including more than 65 million moderate-to-severe COPD patients (Ferkol and Schraufnagel, 2014). COPD is the third leading cause of death globally (World Health Organization, 2014). Anesthesia and Laryngeal Masks are highly involved with the therapeutic areas for acute and chronic respiratory diseases. A study showed that mortality risk reduced by over 60% on a relative basis using long-term non-invasive ventilation for COPD patients (Kohnlein et al., 2014). patients also experienced an improvement in quality of life and exercise capacity.

The rising number of COPD patients results in an increase in the size of the acute care hospitals market and the home care market. Anesthesia and Laryngeal Masks are commonly used in hospitals, home settings, and long-term care facilities, as patient interfaces for non-invasive ventilators or positive airway pressure devices. They are available from device manufacturers and third party suppliers. The choice of different interfaces depends on ventilation efficacy and the patient's tolerance of the ventilation.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Anesthesia and Laryngeal Masks and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Anesthesia and Laryngeal Masks market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Anesthesia and Laryngeal Masks market.
• Competitive dynamics insights and trends provided for Anesthesia and Laryngeal Masks market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Teleflex Inc, Intersurgical Ltd., Medline Industries Inc, Ambu A/S, Medtronic Plc, Vyaire Medical Inc, ICU Medical Inc, Flexicare Group Ltd, Draegerwerk AG & Co KGaA, Jiangsu Weikang Jiejing Medical Apparatus Co Ltd, Cardinal Health Inc, Vygon SA and Others

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Anesthesia and Laryngeal Masks marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Anesthesia & Laryngeal Masks market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Anesthesia & Laryngeal Masks market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Anesthesia & Laryngeal Masks market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Anesthesia & Laryngeal Masks market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable